Wikipedia:Articles for deletion/ProPlus


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was   redirect to Caffeine tablets. Cirt (talk) 18:20, 13 October 2009 (UTC)

ProPlus

 * – (View AfD) (View log)

Non-notable tablet Orange Mike   &#x007C;   Talk  18:10, 29 September 2009 (UTC)

 Please add new comments below this notice. Thanks, Tim Song (talk) 01:05, 6 October 2009 (UTC)
 * Delete per nom. You're right, this probably isn't a good CSD candidate. It's still non-notable and does not meet the criteria for inclusion. A little insignificant Talk to me! (I have candy!) 18:15, 29 September 2009 (UTC)
 * Comment. The article is too short to be worthwhile but Pro Plus is very clearly a notable product. There is loads of coverage from Google News, and surely this can be expanded into at least a decent stub? See also Google Books results. Did you not find any of these?--Michig (talk) 19:54, 29 September 2009 (UTC)
 * Comment. It's worth noting that Pro Plus currently redirects to Caffeine tablets, which is probably a good place to redirect to for now, given the current content of the article.--Michig (talk) 20:02, 29 September 2009 (UTC)
 * Relisted to generate a more thorough discussion so consensus may be reached.


 * Redirect to Caffeine tablets. Based on the number of times it is mentioned as an example, ProPlus is certainly a popular brand of caffeine, but I have not found any coverage specifically about this product except to give the dosage. If there is a List of pharmaceuticals produced by Bayer or somesuch, that would also work as a target. - 2/0 (cont.) 00:36, 13 October 2009 (UTC)
 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.